Farmax India

FARMAXINDIA02 Jul 2018

FMCG

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Farmax India

Farmax India

FMCG

FARMAXINDIA02 Jul 2018

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
13-May-2010	S	Farmax India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 13, 2010, has considered and approved the following items of business: 1. To sub-divide the face value of equity shares having the present value of Rs. 5/- into five equity shares of Re. 1/- each. Farmax India Ltd has informed BSE that the members of the Company, by way of Postal Ballot have approved the Ordinary Resolution under Sections 94 and 16 of the Companies Act, 1956 for Sub-division of One fully paid up Equity Share of Face Value of Rs. 5/- (Rupees Five Only) each into 5 (Five) Equity Shares of Face Value of Re. 1/- (Rupee One only) each fully paid up and alteration of Memorandum of Association of the Company accordingly, with the requisite majority. (As Per BSE Announcement Dated on 24.06.2010) SUB. :- Sub Division of equity shares of Farmax India Limited (Scrip Code 590094) Trading Members of the Exchange are hereby informed that, Farmax India Limited has fixed the Record Date for the purpose of sub division of equity shares of the company. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Farmax India Limited (590094) RECORD DATE 04/08/2010 PURPOSE Sub Division of existing equity shares from every ONE equity share of Rs.5/- each into FIVE equity shares of Re.1/- each. SUB-DIVIDED PAID-UP VALUE Re.1/- SUB-DIVIDED PAID-UP VALUE W.E.F. 03/08/2010 DR-089/2010-2011 Note :- i. Trading members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Re. 1/- paid up w.e.f. 03/08/2010. ii. ISIN No. INE 890I 01027 of Rs.5/- paid up will not be valid for transactions done on the Exchange on or after 03/08/2010. iii. The new ISIN Number for Re.1/- paid up will be informed to the market by a separate notice. (As Per BSE Notice dated on 14.07.2010)	04-Aug-2010
02-Dec-2009	S	Farmax Retail (India) Ltd has informed BSE that the Board of Directors of the Company at its meeting held on December 02, 2009, inter alia, has considered and approved the following: Sub-division of the face value of equity shares having the present value of Rs. 10/- each into 2 (two) equity shares of Rs. 5/- each. Farmax Retail (India) Ltd has informed BSE that the members at the Extra Ordinary General Meeting (EGM) of the Company held on January 01, 2010, inter alia, have approved the following: Sub-division of the face value of equity shares having the present value of Rs. 10/- each into 2 (two) equity shares of Rs. 5/- each. (As Per BSE Announcement Dated on 04/01/2010) SUB. :- Sub Division of equity shares of Farmax Retail (India) Limited (Scrip Code 590094) Trading Members of the Exchange are hereby informed that, Farmax Retail (India) Limited has fixed the Record Date for the purpose of sub division of equity shares of the company. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Farmax Retail (India) Limited (590094) RECORD DATE 28/01/2010 PURPOSE Sub Division of existing equity shares from every ONE equity share of Rs.10/- each into TWO equity shares of Rs.5/- each. SUB-DIVIDED PAID-UP VALUE Rs.5/- SUB-DIVIDED PAID-UP VALUE W.E.F. 27/01/2010 DR- 203/2009- 2010 Note :- i. Trading members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Rs.5/- paid up w.e.f. 27/01/2010. ii. ISIN No. INE890I01019 of Rs.10/- paid up will not be valid for transactions done on the Exchange on or after 27/01/2010. iii. The new ISIN Number for Rs.5/- paid up will be informed to the market by a separate notice. (As Per BSE Notice Dated on 19.01.2010)	28-Jan-2010
18-Jun-2020	BC	Sub:Delisting of equity shares of w.e.f.July10,2020 In terms of Regulation 22(6) of the Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009 ('Regulations'), Sectio	10-Jul-2020
01-Oct-2018	BC	Farmax India Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 29, 2018	29-Sep-2018
25-Jun-2018	BC	Sub : Complete suspension of trading in Equity Shares of Farmax India Limited for non- compliance with Reg. 55A of Depositories and Participants Regulations 1996. This is in continuation to Ex	03-Jul-2018
29-May-2018	BC	Farmax India Limited has informed the Exchange regarding Board meeting held on May 29, 2018. Declaration of audited financials and audited report for the financial quarter and year ended 31.03.2018.	29-May-2018
30-Apr-2018	BC	Farmax India Limited has informed the Exchange regarding Proceedings of Court Convened General Meeting held on April 30, 2018 Farmax India Limited has submitted the Exchange a copy Srutinizers rep	30-Apr-2018

No Rights has been declared by FARMAXINDIA

Book Closure

Record Date	Split Date	Purpose
10-Jul-2020	-	Sub:Delisting of equity shares of w.e.f.July10,2020 In terms of Regulation 22(6) of the Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009 ('Regulations'), Sectio
29-Sep-2018	-	Farmax India Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 29, 2018
03-Jul-2018	-	Sub : Complete suspension of trading in Equity Shares of Farmax India Limited for non- compliance with Reg. 55A of Depositories and Participants Regulations 1996. This is in continuation to Ex
29-May-2018	-	Farmax India Limited has informed the Exchange regarding Board meeting held on May 29, 2018. Declaration of audited financials and audited report for the financial quarter and year ended 31.03.2018.
30-Apr-2018	-	Farmax India Limited has informed the Exchange regarding Proceedings of Court Convened General Meeting held on April 30, 2018 Farmax India Limited has submitted the Exchange a copy Srutinizers rep

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Farmax India Ltd ₹0.05(0.00/0.00%)	0.05	+0.00	2.67	0.00	0.00	0.18
Vadilal Industries Ltd ₹4,684.05(-99.35/-2.08%)	4,684.05	-99.35	3,367.83	136.88	35.67	11.57
Hatsun Agro Product Ltd ₹1,071.25(-21.30/-1.95%)	1,071.25	-21.30	23,861.91	21.89	89.27	15.18
Dabur India Ltd ₹531.75(+6.45/1.23%)	531.75	+6.45	94,228.18	-1.15	63.55	14.15
Agro Tech Foods Ltd ₹734.55(-11.95/-1.60%)	734.55	-11.95	1,790.10	-6.17	233.02	3.58
Hindustan Unilever Ltd ₹2,217.05(-9.25/-0.42%)	2,217.05	-9.25	520,916.13	-10.82	51.13	10.21

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 18	Dec 17	Sep 17	Jun 17	Mar 17	Dec 16
Gross Sales	0.00	0.00	0.00	0.09	0.10	0.11
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.00	0.00	0.00	0.09	0.10	0.11
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.00	0.00	0.00	0.00	0.00	0.00
Total Income	0.00	0.00	0.00	0.09	0.10	0.11
Total Expenditure	0.03	0.03	0.00	0.11	0.01	0.60
PBIDT	-0.03	-0.03	0.00	-0.02	0.09	-0.49
Interest	0.00	0.00	0.00	0.00	0.00	0.00
PBDT	-0.03	-0.03	0.00	-0.02	0.09	-0.49
Depreciation	0.27	0.27	0.32	0.32	0.34	0.32
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	-0.30	-0.30	-0.32	-0.35	-0.25	-0.81
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-0.30	-0.30	-0.32	-0.35	-0.25	-0.81

EPS (Unit Curr.)	-0.02	-0.01	-0.01	-0.06	0.00	-0.02
EPS (Adj) (Unit Curr.)	-0.02	-0.01	-0.01	-0.06	0.00	-0.02
Calculated EPS (Unit Curr.)	-0.01	-0.01	-0.01	-0.01	0.00	-0.02
Calculated EPS (Adj) (Unit Curr.)	-0.01	-0.01	-0.01	-0.01	0.00	-0.02
Calculated EPS (Ann.) (Unit Curr.)	-0.02	-0.02	-0.02	-0.03	-0.02	-0.06
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-0.02	-0.02	-0.02	-0.03	-0.02	-0.06
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	53.42	53.42	53.41	53.42	53.42	53.41
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	1.00	1.00	1.00	1.00	1.00	1.00

Public Shareholding (No. Of Shares)	0.00	331790000.00	331790000.00	0.00	0.00	331790016.00
Public Shareholding (% in Equity)	0.00	62.11	62.11	0.00	0.00	62.11

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	202378000.00	202378000.00	0.00	0.00	202378000.00
Non Encumbered - % in Total Promoters Holding	0.00	100.00	100.00	0.00	0.00	100.00
Non Encumbered - % in Total Equity	0.00	37.89	37.89	0.00	0.00	37.89

PBIDTM(%)	0.00	0.00	0.00	-22.22	90.00	-445.45
PBDTM(%)	0.00	0.00	0.00	-22.22	90.00	-445.45
PATM(%)	0.00	0.00	0.00	-388.89	-250.00	-736.36

Column	Mar 17	Dec 16	Sep 16	Jun 16	Mar 16	Dec 15
Gross Sales	0.10	0.11	1.86	2.32	2.85	4.14
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.10	0.11	1.86	2.32	2.85	4.14
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.05
Other Income	0.00	0.00	0.00	0.04	0.09	0.00
Total Income	0.10	0.11	1.86	2.36	2.94	4.19
Total Expenditure	0.01	0.60	2.19	3.05	3.14	8.83
PBIDT	0.09	-0.49	-0.33	-0.70	-0.20	-4.64
Interest	0.00	0.00	0.00	0.00	0.00	0.00
PBDT	0.09	-0.49	-0.33	-0.70	-0.20	-4.64
Depreciation	0.34	0.32	0.33	0.32	0.36	0.42
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	-0.25	-0.81	-0.66	-1.02	-0.56	-5.06
Minority Interest After NP	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit after Minority Interest	-0.25	-0.81	-0.66	-1.02	-0.56	-5.06

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-0.25	-0.81	-0.66	-1.02	-0.56	-5.06

EPS (Unit Curr.)	-0.04	-0.02	-0.01	-0.02	0.02	-0.09
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	53.42	53.41	53.41	53.42	53.42	53.41

Public Shareholding (Number)	0.00	331790000.00	331790000.00	0.00	0.00	331790000.00
Public Shareholding (%)	0.00	62.11	62.11	0.00	0.00	62.11

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	202378000.00	202378000.00	0.00	0.00	202378000.00
Non Encumbered - % in Total Promoters Holding	0.00	100.00	100.00	0.00	0.00	100.00
Non Encumbered - % in Total Equity	0.00	37.89	37.89	0.00	0.00	37.89

PBIDTM(%)	90.00	-445.45	-17.74	-30.17	-7.02	-112.08
PBDTM(%)	90.00	-445.45	-17.74	-30.17	-7.02	-112.08
PATM(%)	-250.00	-736.36	-35.48	-43.97	-19.65	-122.22

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 16	Mar 15	Mar 14	Mar 13	Mar 12	Mar 11
SOURCES OF FUNDS :
Share Capital	53.42	53.42	40.83	40.83	25.83	25.83
Reserves Total	-62.39	-52.61	-54.53	-45.69	75.03	316.17
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	-8.97	0.81	-13.70	-4.86	100.86	342.00
Secured Loans	41.00	41.02	41.49	29.67	30.07	24.25
Unsecured Loans	0.00	0.00	0.00	5.71	0.00	12.95
Total Debt	41.00	41.02	41.49	35.38	30.07	37.20
Total Liabilities	32.03	41.83	27.79	30.52	130.93	379.20
APPLICATION OF FUNDS :
Gross Block	36.38	37.29	37.10	37.09	36.95	38.88
Less : Accumulated Depreciation	18.01	17.22	15.05	13.11	10.65	7.98
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	18.37	20.07	22.05	23.98	26.30	30.90
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.34	253.34
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	1.94	8.85	3.36	2.83	15.04	11.27
Sundry Debtors	6.19	6.93	0.17	0.16	16.93	15.50
Cash and Bank	0.20	0.24	0.01	0.09	0.03	0.04
Loans and Advances	1.79	3.26	0.02	0.05	4.05	7.18
Total Current Assets	10.13	19.28	3.57	3.13	36.06	33.99
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	1.64	2.75	2.86	1.88	2.98	6.53
Provisions	0.19	0.16	0.30	0.09	0.20	1.46
Total Current Liabilities	1.83	2.91	3.16	1.97	3.18	7.99
Net Current Assets	8.30	16.37	0.41	1.16	32.88	26.00
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.78	0.13
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.05	0.00
Net Deferred Tax	0.00	0.00	0.00	0.00	0.73	0.13
Total Assets	26.67	36.44	22.46	25.14	60.24	310.37
Contingent Liabilities	0.00	0.00	0.00	0.52	5.24	0.00

Column	Mar 16	Mar 15	Mar 14	Mar 13	Mar 12	Mar 11
SOURCES OF FUNDS :
Share Capital	53.42	53.42	40.83	40.83	25.83	25.83
Reserves Total	-62.60	-52.77	-54.65	-45.76	84.76	316.26
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	-9.18	0.65	-13.82	-4.93	110.59	342.09
Minority Interest	0.00	0.00	0.00	0.00	0.00	0.00
Secured Loans	41.00	41.02	41.49	29.67	30.07	26.37
Unsecured Loans	0.00	0.00	0.00	5.71	0.00	12.95
Total Debt	41.00	41.02	41.49	35.38	30.07	39.32
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	31.82	41.67	27.67	30.45	140.66	381.41
APPLICATION OF FUNDS :
Gross Block	36.38	37.29	37.10	37.09	36.95	38.87
Less: Accumulated Depreciation	18.01	17.22	15.05	13.11	10.66	7.98
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	18.37	20.07	22.05	23.98	26.29	30.89
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.16	253.16
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	1.94	8.85	3.36	2.83	15.04	11.27
Sundry Debtors	6.19	6.93	0.17	0.16	16.93	27.82
Cash and Bank	0.20	0.24	0.01	0.09	0.04	0.11
Loans and Advances	1.79	3.26	0.02	0.05	83.86	74.52
Total Current Assets	10.13	19.28	3.57	3.13	115.87	113.72
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	1.64	2.75	2.86	1.88	3.25	17.00
Provisions	0.40	0.33	0.42	0.17	0.00	1.46
Total Current Liabilities	2.04	3.08	3.28	2.04	3.25	18.46
Net Current Assets	8.09	16.20	0.28	1.08	112.62	95.26
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.78	0.13
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.05	0.00
Net Deferred Tax	0.00	0.00	0.00	0.00	0.73	0.13
Other Assets	5.36	5.40	5.33	5.38	0.86	1.95
Total Assets
Contingent Liabilities	0.00	0.00	0.00	5.24	5.24	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012
Cash and Cash Equivalents at Beginning of the year	0.24	0.01	0.08	0.03	0.04
Net Cash from Operating Activities	-0.41	-17.43	-0.46	-19.95	-2.85
Net Cash Used In Investing Activities	1.22	1.56	0.42	-3.78	1.26
Net Cash Used In Financing Activities	-4.06	16.09	-0.03	23.79	1.58
Net Inc./Dec In Cash And Cash Equivalents	-3.25	0.22	-0.07	0.06	-0.01
Cash And Cash Equivalents At End Of The Year	-3.02	0.24	0.01	0.09	0.03

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

30.98%

FII Shareholding

0.84%

DII Shareholding

0.00%

Public Shareholding

68.18%

**Promoter pledged shareholding 30.98%

About Farmax India Ltd

Farmax India Ltd is in the FMCG sector, having a market capitalization of Rs. 2.67 crores. It has reported a sales of Rs. 0 crores and a net profit of Rs. -0.3 crores for the quarter ended December 2018. The company management includes M Srinivasa Reddy, M Srinivasa Reddy,A V Rama Raju,P Priyanka,Sudheer Reddy (Farmax India Ltd) among others.

Chairman

M Srinivasa Reddy

Registered office

Survey No 658 Bowrampet Villag,Qutubullapur Mandal,Ranga Reddy,Telangana,500043

FAX :91-08418-23065762

Background

Incorporation Year1995

Face Value₹1

Market Lot1

How to buy Farmax India shares on nse?

To buy Farmax India shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Farmax India share price today?

The Farmax India shares price on nse is Rs.0.05 today.

What is the market cap of Farmax India shares on NSE ?

The company has a market capitalization of Rs.2.67Cr

What is the PE & PB ratio of Farmax India shares ?

PE is 0 and PB is 0.18

What is the 52 Week High and Low of Farmax India shares?

Farmax India stock price high: Rs.0.05 Farmax India stock price low: Rs.0